Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation

Research in Veterinary Science

Volumn 79, Issue 1, 2005, Pages 69-76

  Mischke, Reinhard ^a   Fehr, Michael ^a   Nolte, Ingo ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Disseminated intravascular coagulopathy (DIC); Dog; Low molecular weight heparin; Thromboplastin

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; FIBRINOGEN; FRAGMIN D; LOW MOLECULAR WEIGHT HEPARIN; THROMBOPLASTIN;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULANT THERAPY; ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DOG DISEASE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FIBRINOGEN BLOOD LEVEL; MALE; NONHUMAN; THROMBOCYTE COUNT;

ANIMALS; ANTICOAGULANTS; DISSEMINATED INTRAVASCULAR COAGULATION; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; MALE; THROMBOPLASTIN;

ANIMALIA; CANIS FAMILIARIS;

EID: 18444389177     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2004.10.006     Document Type: Article

References (37)

1. E. Adelson J.J. Rheingold O. Parker Platelet and fibrinogen sequestration Blood 15 1960 596-605
2. G. Audibert H. Lambert F. Toulemonde P. Alexandre M.C. Laprevote-Heully P.E. Bollaert P. Bauer A. Larcan Utilisation d'une heparine de bas poids moleculaire, la CY 222, dans le traitement des coagulopathies de consommation Journal des Maladies Vasculaires 12 1987 147-151
3. S.W. Bateman K.A. Mathews A.C. Abrahms-Ogg J.H. Lumsden I.B. Johnstone T.K. Hillers R.A. Foster Diagnosis of disseminated intravascular coagulation in dogs admitted to intensive care unit Journal of the American Veterinary Medical Association 215 1999 798-804
4. U. Becker K. Bartl A.W. Wahlefeld A functional photometric assay for plasma fibrinogen Thrombosis Research 35 1984 475-484
5. H. Bergmann B. Blauhut S. Necek H. Kramar H. Vinazzer Heparinprophylaxe der Verbrauchskoagulopathie bei Schockpatienten. Abḧngigkeit der Wirkung von der verfügbaren Antithrombin III-Aktivität Anästhesist 29 1980 623-626
6. R.L. Bick Disseminated intravascular coagulation: A review of etiology, pathophysiology, diagnosis and management: Guidelines for care Clinical and applied thrombosis/hemostasis 8 2002 1-31
7. R.L. Bick M.D. Bick L.F. Fekete Antithrombin III patterns in disseminated intravascular coagulation American Journal of Clinical Pathology 73 1980 577-583
8. J.F. Cade M.R. Buchanan B. Boneu P. Ockelford C.J. Carter A.L. Cerskus J. Hirsh A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation Thrombosis Research 35 1984 613-625
9. R.W. Colman S.J. Robboy J.D. Minna Disseminated intravascular coagulation (DIC): An approach The American Journal of Medicine 52 1972 679-689
10. E. De Jonge M. Levi C.P. Stoutenbeek S.J. van Deventer Current drug treatment strategies for disseminated intravascular coagulation Drugs 55 1998 767-777
11. J. Denton D.A. Lane L. Thunberg A.M. Slater U. Lindahl Binding of platelet factor 4 to heparin oligosaccharides The Biochemical Journal 209 1983 455-460
12. B.F. Feldman B.R. Madewell S. O'Neill Disseminated intravascular coagulation: Antithrombin, plasminogen, and coagulation abnormalities in 41 dogs Journal of the American Veterinary Medical Association 179 1981 151-154
13. B.F. Feldman R. Kirby M. Caldin Recognition and treatment of disseminated intravascular coagulation In: J.D. Bonagura (Ed.) Kirk's current veterinary therapy XIII 2000 W.B. Saunders Company Philadelphia 190-194
14. Y. Fujishima K. Yokota T. Sukamoto The effect of danaparoid sodium (danaparoid) on endotoxin-induced experimental disseminated intravascular coagulation in rats Thrombosis Research 91 1998 221-227
15. S. Grebe C. Jacobs M. Kietzmann R. Mischke Pharmakokinetik des niedermolekularen Heparins Fragmin® D beim Hund Berliner und Münchener Tierärztliche Wochenschrift 113 2000 103-107
16. S. Hamano M. Kinukawa H. Komatsu H. Miyata N. Sakuragawa Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models Nippon Yakurigaku Zasshi (Japanese Journal of Pharmacology) 98 1991 53-62
17. A.S. Hammer C.G. Couto C. Swardson D. Getzy Hemostatic abnormalities in dogs with hemangiosarcoma Journal of Veterinary Internal Medicine 5 1991 11-14
18. L.J. Hellebrekers R.J. Slappendel W.E. Van den Brom Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog American Journal of Veterinary Research 46 1985 1460-1462
19. M. Hofmann A. Rest G. Hafner W. Prellwitz P. Brockerhoff L.S. Weilemann Niedermolekulares Heparin (Fragmin®) in der Therapie der Sepsis mit Gerinnungsstörungen - vergleichende Untersuchung zweier Dosierungsschemata Intensivmedizin 34 1997 124-130
20. S.A. Holloway Disseminated intravascular coagulation in: M.J. Day A. Mackin J.D. Littlewood (Eds.) BSAVA Manual of canine and feline haematology and transfusion medicine 2000 British Small Animal Veterinary Association Quedgeley, UK 253-260
21. E. Holmer Anticoagulant properties of heparin and heparin fractions Scandinavian Journal of Haematology 25 Suppl. 36 1980 25-39
22. G.J. Kociba Disseminated intravascular coagulation In: R.W. Kirk (Ed.) Current veterinary therapy VI 1977 W.B. Saunders Company Philadelphia 448-451
23. G.A. Marbet M.J. Griffith Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs Thrombosis and Haemostasis 55 1986 78-85
24. D.L. Millis J.G. Hauptman R.B. Fulton Abnormal hemostatic profiles and gastric necrosis in canine gastric dilatation-volvulus Veterinary Surgery 22 1993 93-97
25. S.K. Minn E.E. Mandel Experimental disseminated intravascular coagulation. Effect of heparin and epsilon-aminocaproic acid on tests of hemostatic function Thrombosis Research 6 1975 235-246
26. R. Mischke Optimization of coagulometric tests that incorporate human plasma for determination of coagulation factor activities in canine plasma American Journal of Veterinary Research 62 2001 625-629
27. R. Mischke S. Grebe C. Jacobs M. Kietzmann Amidolytic heparin activity and values for several hemostatic variables after repeated subcutaneous administration of high doses of a low molecular weight heparin in healthy dogs American Journal of Veterinary Research 62 2001 595-598
28. F.A. Ofosu A.L. Cerskus J. Hirsh L.M. Smith G.J. Modi M.A. Blajchman The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids and tissue factor British Journal of Haematology 57 1984 229-238
29. Y. Oguma N. Sakuragawa M. Maki M. Nakagawa H. Hasegawa Clinical effect of low molecular weight heparin (fragmin) on DIC: A multicenter cooperative study in Japan Thrombosis Research 59 1990 37-49
30. C.A. Owen E.J.W. Bowie Effect of heparin on chronically induced intravascular coagulation in dogs The American Journal of Physiology 229 1975 449-454
31. W. Ruehl C. Millis B.F. Feldman Rational therapy in disseminated intravascular coagulation Journal of the American Veterinary Medical Association 181 1982 76-78
32. M.M. Samama G.T. Gerotziafas Comparative pharmacokinetics of LMWHs Seminars in Thrombosis and Hemostasis 26 Suppl. 1 2000 31-38
33. R.J. Slappendel Disseminated intravascular coagulation Veterinary Clinics of North America Small Animal Practice 18 1988 169-184
34. H.P. Smith E.D. Warner K.M. Brinkhous Prothrombin deficiency and the bleeding tendency in liver injury (chloroform intoxication) The Journal of Experimental Medicine 66 1937 801-811
35. Y. Takahashi Y. Hosaka K. Imada T. Adachi H. Niina M. Watanabe H. Mochizuk Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: Comparison with low molecular weight heparin Thrombosis and Haemostasis 77 1997 789-795
36. H. Tanaka N. Kobayashi T. Maekawa Studies on production of antithrombin III with special reference to endotoxin-induced DIC in dogs Thrombosis and Haemostasis 56 1986 137-143
37. S. Tazawa K. Ichikawa K. Misawa J. Fukuyama S. Hamano H. Miyata N. Sakuragawa Effects of low molecular weight heparin on a severely antithrombin III decreased disseminated intravascular coagulation model in rabbits Thrombosis Research 80 1995 391-398